Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Onconova Therapeutics Inc (NASDAQ:ONTX)

0.4706
Delayed Data
As of Apr 29
 +0.0006 / +0.13%
Today’s Change
0.32
Today|||52-Week Range
4.00
-50.82%
Year-to-Date
No recent news for Onconova Therapeutics Inc.

Today’s Trading

Previous close0.47
Today’s open0.48
Day’s range0.47 - 0.52
Volume107,879
Average volume (3 months)148,965
Market cap$12.9M
Dividend yield--
Data as of 3:58pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+64.29%
Earnings growth (this year)+29.52%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,332.00%
P/E ratioNM
Price/Sales1.90
Price/Book1.20

Competitors

 Today’s
change
Today’s
% change
GNVCGenVec Inc-0.01-1.28%
HTBXHeat Biologics Inc-0.01-2.08%
NEOTNeothetics Inc-0.13-12.80%
RTTRRitter Pharmaceutica...+0.02+1.24%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 12, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$11.5M
Annual profit (last year)-$24.0M
Net profit margin-209.31%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ramesh Kumar
Chief Financial &
Accounting Officer
Mark Guerin
Corporate headquarters
Newtown, Pennsylvania

Forecasts

Partner Offers

Search for Jobs